C4 Therapeutics, Inc. - CCCC
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | — | A | A | 4,259.0 | 2.7 | 11,499.3 | 68,230.0 | View | |
| Apr 03, 2026 | — | A | A | 5,370.0 | 2.7 | 14,499.0 | 71,512.0 | View | |
| Feb 18, 2026 | Chief Business Officer | F | D | 7,269.0 | 1.89 | 13,738.41 | 298,801.0 | View | |
| Feb 18, 2026 | Chief Business Officer | M | A | 20,950.0 | 0.0 | 0.0 | 306,070.0 | View | |
| Feb 18, 2026 | Chief Business Officer | F | D | 1,735.0 | 1.89 | 3,279.15 | 306,070.0 | View | |
| Feb 18, 2026 | Chief Business Officer | M | A | 5,000.0 | 0.0 | 0.0 | 307,805.0 | View | |
| Feb 18, 2026 | Chief Business Officer | A | A | 200,000.0 | 0.0 | 0.0 | 307,805.0 | View | |
| Feb 18, 2026 | Chief Medical Officer | F | D | 16,579.0 | 1.89 | 31,334.31 | 379,803.0 | View | |
| Feb 18, 2026 | Chief Medical Officer | M | A | 30,950.0 | 0.0 | 0.0 | 396,382.0 | View | |
| Feb 18, 2026 | Chief Medical Officer | A | A | 240,000.0 | 0.0 | 0.0 | 396,382.0 | View | |
| Feb 18, 2026 | Chief Financial Officer | F | D | 15,381.0 | 1.89 | 29,070.09 | 385,098.0 | View | |
| Feb 18, 2026 | Chief Financial Officer | M | A | 30,950.0 | 0.0 | 0.0 | 400,479.0 | View | |
| Feb 18, 2026 | Chief Financial Officer | F | D | 1,863.0 | 1.89 | 3,521.07 | 400,479.0 | View | |
| Feb 18, 2026 | Chief Financial Officer | M | A | 3,750.0 | 0.0 | 0.0 | 402,342.0 | View | |
| Feb 18, 2026 | Chief Financial Officer | A | A | 240,000.0 | 0.0 | 0.0 | 402,342.0 | View | |
| Feb 18, 2026 | Chief Accounting Officer | F | D | 3,268.0 | 1.89 | 6,176.52 | 71,916.0 | View | |
| Feb 18, 2026 | Chief Accounting Officer | M | A | 9,420.0 | 0.0 | 0.0 | 75,184.0 | View | |
| Feb 18, 2026 | Chief Accounting Officer | A | A | 56,980.0 | 0.0 | 0.0 | 75,184.0 | View | |
| Feb 18, 2026 | Chief People Officer | F | D | 7,269.0 | 1.89 | 13,738.41 | 299,881.0 | View | |
| Feb 18, 2026 | Chief People Officer | M | A | 20,950.0 | 0.0 | 0.0 | 307,150.0 | View | |
| Feb 18, 2026 | Chief People Officer | F | D | 1,735.0 | 1.89 | 3,279.15 | 307,150.0 | View | |
| Feb 18, 2026 | Chief People Officer | M | A | 5,000.0 | 0.0 | 0.0 | 308,885.0 | View | |
| Feb 18, 2026 | Chief People Officer | A | A | 200,000.0 | 0.0 | 0.0 | 308,885.0 | View | |
| Feb 18, 2026 | President & CEO | F | D | 9,057.0 | 1.89 | 17,117.73 | 1,074,934.0 | View | |
| Feb 18, 2026 | President & CEO | M | A | 20,400.0 | 0.0 | 0.0 | 1,083,991.0 | View | |
| Feb 18, 2026 | President & CEO | F | D | 39,154.0 | 1.89 | 74,001.06 | 1,083,991.0 | View | |
| Feb 18, 2026 | President & CEO | M | A | 81,725.0 | 0.0 | 0.0 | 1,123,145.0 | View | |
| Feb 18, 2026 | President & CEO | A | A | 700,000.0 | 0.0 | 0.0 | 1,123,145.0 | View | |
| Feb 18, 2026 | Chief Scientific Officer | F | D | 2,446.0 | 1.89 | 4,622.94 | 336,910.0 | View | |
| Feb 18, 2026 | Chief Scientific Officer | M | A | 7,050.0 | 0.0 | 0.0 | 339,356.0 | View | |
| Feb 18, 2026 | Chief Scientific Officer | A | A | 240,000.0 | 0.0 | 0.0 | 339,356.0 | View | |
| Jan 16, 2026 | Chief Medical Officer | S | D | 10,000.0 | 2.22 | 22,200.0 | 156,382.0 | View | |
| Jan 05, 2026 | — | A | A | 7,513.0 | 1.93 | 14,500.09 | 66,142.0 | View | |
| Jan 05, 2026 | — | A | A | 5,958.0 | 1.93 | 11,498.94 | 146,532.0 | View | |
| Oct 30, 2025 | Chief Scientific Officer | F | D | 5,644.0 | 2.58 | 14,561.52 | 99,356.0 | View | |
| Oct 30, 2025 | Chief Scientific Officer | M | A | 19,200.0 | 0.0 | 0.0 | 105,000.0 | View |